Tech : 9093 – – Saliva-based Testing Devices Manufacturer with Patented Products and Technologies.
This 15-year old, global company is a leading company in the emerging field of non-invasive saliva based testing. It was founded to address the need for rapid testing, sample collection, and molecular diagnostics (DNA, RNA and proteins) in the life sciences area. The company continues to meet the need for more effective screening tools utilizing non-invasive test specimens, particularly oral fluids, which may be applied to the early detection of a wide range of diseases and medical disorders. The company has important licenses to salivary technologies for Alzheimer’s disease, Parkinson’s disease and sleep disorders, allowing for the future development of rapid, non-invasive tests for these debilitating diseases / disorders.
Products include a wide range of innovative saliva / oral fluid collection devices, and breakthrough point-of-care test platform device. This device has been used for developing test for stress by measuring cortisol levels in saliva in real time. This device may be applied to the development of multiple diseases or multiple biomarkers in 20 minutes, eliminating the pain associated with a blood draw. The company’s range of collection and future diagnostic tools are covered by a portfolio of 16 issued US, EU and International patents with a further 10 or more in the application phase.
The Company has successfully received grant funding in the past from both the National Institutes of Health and the Michael J Fox Foundation, among others.
The company is looking for a strategic buyer / partner. Revenues: US $2.14 million (2016), Projected Revenues: $3.3 million (2017); $7.5 million (2018); $11.3 million (2019)